Plasma sphingomyelin and longitudinal change in percent emphysema on CT. The MESA Lung study

Ahmed, Firas S.; Jiang, Xian-cheng; Schwartz, Joseph E.; Hoffman, Eric A.; Yeboah, Joseph; Shea, Steven J. C.; Burkart, Kristin Marie; Barr, R. Graham

Context: Ceramide causes endothelial apoptosis and emphysema-like changes in animal models.

Objectives: Test if plasma sphingomyelin, a major precursor of ceramide, would predict longitudinal increase in the percentage of emphysema-like lung on computed tomography (CT).

Materials and methods: 3840 participants had their plasma sphingomyelin measured at baseline examination and their pulmonary emphysema measured on cardiac CT scans at baseline and on follow-up visits. Mixed effects models were used to adjust for potential confounders.

Results: One standard deviation increase in sphingomyelin predicted a 0.12% per year (95% CI: 0.02–0.22; p = 0.019) greater increase of percent emphysema.

Discussion and conclusion: Higher plasma levels of sphingomyelin predicted greater annual increase in quantitatively measured percent emphysema.


  • thumnail for Ahmed_Biomarkers_2014_PMC.pdf Ahmed_Biomarkers_2014_PMC.pdf application/pdf 222 KB Download File

Also Published In

More About This Work

Academic Units
Center for Behavioral Cardiovascular Health
Taylor & Francis
Published Here
September 12, 2016